The latest closing stock price for Barinthus Biotherapeutics as of January 31, 2025 is 1.10.
An investor who bought $1,000 worth of Barinthus Biotherapeutics stock at the IPO in 2021 would have $-922 today, roughly -1 times their original investment - a -47.21% compound annual growth rate over 4 years.
The all-time high Barinthus Biotherapeutics stock closing price was 17.00 on May 17, 2021.
The Barinthus Biotherapeutics 52-week high stock price is 4.16, which is 278.2% above the current share price.
The Barinthus Biotherapeutics 52-week low stock price is 0.80, which is 27.3% below the current share price.
The average Barinthus Biotherapeutics stock price for the last 52 weeks is 1.70.
An investor who bought $1,000 worth of Barinthus Biotherapeutics stock at the IPO in 2021 would have $-922 today, roughly -1 times their original investment - a -47.21% compound annual growth rate over 4 years.
The all-time high Barinthus Biotherapeutics stock closing price was 17.00 on May 17, 2021.
The Barinthus Biotherapeutics 52-week high stock price is 4.16, which is 278.2% above the current share price.
The Barinthus Biotherapeutics 52-week low stock price is 0.80, which is 27.3% below the current share price.
The average Barinthus Biotherapeutics stock price for the last 52 weeks is 1.70.